Inventor
MCDONALD IVAR M
US28 patents
⚠️ This page may combine multiple inventors who share the name “MCDONALD IVAR M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
24 patentsUS7863291B2Jan 4, 2011
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
BRISTOL MYERS SQUIBB CO22 citations91
US9527871B2Dec 27, 2016
Benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO5 citations84
US9526801B2Dec 27, 2016
Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO13 citations84
US10869934B2Dec 22, 2020
Antiproliferative compounds and conjugates made therefrom
BRISTOL MYERS SQUIBB CO8 citations83
US10398783B2Sep 3, 2019
Antiproliferative compounds and conjugates made therefrom
BRISTOL MYERS SQUIBB CO7 citations83
US11359197B2Jun 14, 2022
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
BRISTOL MYERS SQUIBB CO4 citations81
US11866430B2Jan 9, 2024
Naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO3 citations73
US9708323B2Jul 18, 2017
Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
BRISTOL MYERS SQUIBB CO2 citations73
US9676794B2Jun 13, 2017
Benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO3 citations73
US9796713B2Oct 24, 2017
Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
BRISTOL MYERS SQUIBB CO2 citations72
US11447775B2Sep 20, 2022
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
BRISTOL MYERS SQUIBB CO3 citations70
US10669272B2Jun 2, 2020
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO4 citations70
US11058767B2Jul 13, 2021
CAMK2D antisense oligonucleotides and uses thereof
BRISTOL MYERS SQUIBB CO0 citations60
US12180478B2Dec 31, 2024
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
BRISTOL MYERS SQUIBB CO0 citations59
US11713316B2Aug 1, 2023
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US12077558B2Sep 3, 2024
Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds
BRISTOL MYERS SQUIBB CO0 citations58
US11613554B2Mar 28, 2023
Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds
BRISTOL MYERS SQUIBB CO1 citations58
US10112975B2Oct 30, 2018
Benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO0 citations52
US9822112B2Nov 21, 2017
Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO0 citations52
US9822144B2Nov 21, 2017
Benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO0 citations52
US9676775B2Jun 13, 2017
Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
BRISTOL MYERS SQUIBB CO0 citations52
US12241065B2Mar 4, 2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
BRISTOL MYERS SQUIBB CO0 citations49
US7977362B2Jul 12, 2011
Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
BRISTOL MYERS SQUIBB CO0 citations41